Clinical Significance of Marginal Acute Inflammation for Stage II Colon Cancer
NCT ID: NCT06135558
Last Updated: 2023-11-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1167 participants
OBSERVATIONAL
2016-01-30
2023-10-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Extent of Lymph Node Dissection for Advanced Right-Sided Colon Cance
NCT06986538
Exploration of the Relationship Between Mismatch Repair Status of Colorectal Cancer and Lymph Node Metastasis Patterns and Pathological High-risk Factors
NCT06798857
Tumor Response Prediction in Neoadjuvant Chemoradiation of Locally Advanced Rectal Cancer Using Metabonomics Analysis
NCT03149978
Predicting Response to Chemotherapy in Colorectal Cancer Via Multi-dimensional Analyses of the Tumor Associated Neutrophils
NCT06495827
Study of Association Between Peripheral Immune Cells and Recurrence in Stage II/III Colorectal Cancer
NCT01911988
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
T3
patient staged T3 without marginal acute inflammation
MAI detection
to detect the presence of marginal acute inflammation
MAI
patient with marginal acute inflammation
MAI detection
to detect the presence of marginal acute inflammation
T4
patient staged T4 without marginal acute inflammation
MAI detection
to detect the presence of marginal acute inflammation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MAI detection
to detect the presence of marginal acute inflammation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sun Yat-sen University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yanhong Deng
M.D.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GIH-SYip32
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.